How many insider declarations has Parkman Healthcare Partners LLC filed?

Parkman Healthcare Partners LLC has filed 2 public insider declarations with SEC (Form 4).

What is Parkman Healthcare Partners LLC's role?

Parkman Healthcare Partners LLC's reported role is not specified by the regulator across the filings.

Which companies does Parkman Healthcare Partners LLC report trades for?

Parkman Healthcare Partners LLC reports trades for Spruce Biosciences, INC..

What is Parkman Healthcare Partners LLC's declared buy vs sell volume?

Across the available history, declared buys total 8k€ and disposals 0.

← Executives ★ Sign in to follow

PH

Parkman Healthcare Partners LLC

·SEC (Form 4)

Spruce Biosciences, INC.

0

申报总数

0

公司

€7,831

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-53.9%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Parkman Healthcare Partners LLC. Officer active across 1 company, notably Spruce Biosciences, INC.. Cumulatively, 2 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €8k. History available since 6 October 2025. The latest transaction was disclosed on 6 October 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Parkman Healthcare Partners LLC

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Spruce Biosciences, INC. (US)

申报2 总计

▲

Parkman Healthcare Partners LLC

高管2025年10月6日Spruce Biosciences, INC.

US$4,5850SEC ↗

256 股@ US$17.91080.0027% mcap25.0% 占其流量Common Stock, $0.001 par value per shareSEC:0000919574-25-006126:0

标准退出：2026年1月4日 (T+90)

▲

Parkman Healthcare Partners LLC

高管2025年10月6日Spruce Biosciences, INC.

US$4,58512SEC ↗

256 股@ US$17.91080.0027% mcap25.0% 占其流量Common Stock, $0.001 par value per shareSEC:0000919574-25-006012:0

标准退出：2026年1月4日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

PH

Parkman Healthcare Partners LLC

·SEC (Form 4)

Spruce Biosciences, INC.

0

申报总数

0

公司

€7,831

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-53.9%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Parkman Healthcare Partners LLC. Officer active across 1 company, notably Spruce Biosciences, INC.. Cumulatively, 2 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €8k. History available since 6 October 2025. The latest transaction was disclosed on 6 October 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.